Objectives-To estimate the current prevalence of family history and associated risk of prevalent colorectal cancer among middle aged and older British adults. Methods-Cross sectional analysis of colorectal cancer and self reported family history based on data from a large population based study in Norfolk, United Kingdom. Results-Of the 30 353 participants, 2069 (6.8%) participants had reported a family history of colorectal cancer in at least one first degree relative. The prevalence of colorectal cancer in those with a family history was 1% and 0.5% in those without. Of the 151 participants with prevalent colorectal cancer, 14.6% reported a family history of the disease. Also, a family history of colorectal cancer in first degree relatives was significantly associated with an increased risk of prevalent colorectal cancer (multivariate odds ratio (OR) 2.32 (95% confidence interval (95% CI) 1.43 to 3.76). For those with one aVected relative below the age of 45, and for those with two aVected relatives the multivariate ORs were 5. 29 (1.63 to 17.17) and 4.93 (1.17 to  20.70) , respectively. Conclusions-Although positive family history may identify a group with increased likelihood of colorectal cancer, screening strategies targeted solely at people with a family history will have limited impact on reducing mortality from colorectal cancer at the population level. (J Med Screen 2001;8:69-72) 
Several studies have reported that people with one or more first degree relatives with colorectal cancer have an increased risk of developing the disease themselves. [1] [2] [3] Consequently, these reports have led to recommendations to screen people with a family history of colorectal cancer. Guidelines in the United Kingdom and internationally advocate regular colonoscopy for people with a family history of at least two or more first degree relatives or one relative diagnosed under the age of 45. However, relatively few studies have assessed the risk associated with the number of aVected relatives and their age of diagnosis. 2 3 Also, there are no population based estimates of the prevalence of family history of colorectal cancer in British adults. Thus the impact of targeting screening at people with a family history in the United Kingdom is uncertain. We therefore estimated the current prevalence of family history and associated risk of prevalent colorectal cancer among middle aged and older British adults with data from a large population based study.
Materials and methods
Participants for this analysis were recruited between 1993 and 1997 as part of the East Anglian component of the European Prospective Investigation into Cancer (EPIC-Norfolk). The detailed design of the study has been previously described. 4 Briefly, all men and women aged 45-74 identified from lists of participating general practices were invited to join the study. All participants completed a detailed health and lifestyle questionnaire, which included questions on smoking (current, former, and never), height, weight, level of education (further education), history of disease, and family history of disease. Body mass index was calculated with the formula weight (kg)/height 2 (m). For each relative with a history of colorectal cancer, participants completed questions specifying the age of diagnosis and whether they were still alive. Only family history of first degree relatives was used in this analysis, defined as parents, siblings, or children. Prevalent colorectal cancer (international classification of diseases ninth revision (ICD-9), 5 153.0-153.9, 154.0, and 154.1) was ascertained by matching all participants to the East Anglian cancer registry. For the purposes of these analyses, we excluded all participants with prevalent cancer other than colorectal cancer or non-melanoma skin cancer. An alternative analysis, which excluded those participants who had undergone colonoscopy or related procedures, gave similar results to those reported here. After these exclusions, all remaining cohort participants were used as the control population in these cross sectional analyses of the EPIC cohort. Significance testing was done with t tests for means and 2 tests for proportions. Unconditional multivariate logistic regression was used to measure the association between family history and risk of prevalent colorectal cancer. Maximum likelihood methods were used to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs).
Results
Of the 30 353 participants in this analysis, 2069 (6.8%) reported a family history of colorectal cancer in at least one first degree relative. Of these, 103 (0.3%) people reported a family history in two or more first degree relatives, and 187 (0.6%) participants reported a family history in either two first degree relatives or one diagnosed below the age of 45 years, or both (13 people). Of the 151 participants with prevalent colorectal cancer, 14.6% reported a family history of the disease. Characteristics of the study participants stratified by sex and the presence or absence of a family history of colorectal cancer are shown in table 1.
As well as describing age and sex specific prevalence of family history of colorectal cancer, table 2 shows that risk of colorectal cancer is higher for older participants than for younger ones, as denoted by the age specific ORs. The linear trend for increasing risk with increasing age of proband was significant (p<0.001). Table 3 shows prevalence of family history for cases and controls and a substantial association between variants of family history and risk of prevalent colorectal cancer. The sex specific estimates were only significant for women with a multivariate adjusted OR of 2.77 (95% CI 1.46 to 5.26). Among participants who reported one and two or more first degree relatives with colorectal cancer, the multivariate adjusted ORs were 2.11 (95% CI 1.26 to 3.54) and 5.29 (95% CI 1.63 to 17.17), respectively. The linear trend for increasing risk with increasing number of aVected relatives was significant (p<0.001). There was also a strong association between risk of colorectal cancer and the age that relatives were diagnosed (table 3) . For participants with relatives diagnosed below the age of 45 the multivariate OR was 4.93 (95% CI 1.17 to 20.70), with risk decreasing monotonically with increasing age of diagnosis: the linear trend for increasing risk with decreasing age of diagnosis of relatives was significant (p<0.001).
Discussion
In this large population based study, whose participants are broadly representative of the British population, we have estimated the age and sex specific prevalence of family history of colorectal cancer. This study also confirms that a family history of colorectal cancer in first degree relatives is associated with an increased risk of prevalent colorectal cancer.
It is unlikely that confounding by other risk factors for colorectal cancer and correlates of family history may have explained our findings, 3 and adjustment for potential confounders and their correlates did not significantly modify any of the risk estimates. We did not determine family size in this analysis and family history as a result of large families may have overestimated our results, however, Negri et al, 1 who adjusted for the number of siblings, reported similar findings to ours.
A potential bias in this study is diVerential recall of family history in people who have known colorectal cancer, as family history of colorectal cancer was ascertained by self report. Nevertheless, studies have indicated that recall of family history for cases of colorectal cancer is only marginally better than the recall of controls. 6 7 Also, as risk estimates and the proportion of people reporting a positive family history in this study compare well with reports that used medical records to confirm family history, 6 8 ascertainment bias is unlikely to explain our results. Our estimates are in general agreement with previous reports and reviews. 1-3 8-12 However, this is one of the few studies to report risk estimates based on the age of diagnosis of relatives, for which a monotonic increase in risk was associated with decreasing age of diagnosis of the aVected relative. However, for risk associated with age of diagnosis of the subject, we found an increase in risk with increasing age. Other studies have reported a decreasing risk with increasing age of the subject at diagnosis, 1 3 9 which plausibly suggests that the risk of spontaneous colorectal cancer is more marked at older ages. Our age specific risk estimates, although significant, were based on very few cases and hence may have been a result of sampling variation.
Public awareness of familial risk of cancer is increasing, which may place extra burden on limited primary care resources and demands for screening. From a public health perspective, selection based on family history may substantially increase the frequency of case detection-the positive predictive value or yield 13 for a given sensitivity and specificity of a screening test-relative to those without a family history. However, the absolute increase in yield for a disease of low prevalence (1% in those with and 0.5% in those without a family history of colorectal cancer) will be small. For a screening test with 90% sensitivity and specificity, a change in prevalence from 0.5% to 1% will give a yield of 4.3% and 8.3%, respectively. Moreover, restricting screening to people with a family history will only detect 15% of all prevalent colorectal cancers, as most colorectal cancers (around 85%) will not have a family history. Therefore any intervention targeted at a moderate to high risk group will have limited eYcacy and a very small impact on morbidity and mortality from colorectal cancer in the total population .
High risk people, who comprise <2%-5% of all colorectal cancers and include those with known cancer syndromes-such as familial adenomatous polyposis syndrome (FAP) and hereditary non-polyposis colorectal cancer (HNPCC)-have a lifetime risk of developing colorectal cancer of 80% on average, 14 and are managed according to well defined protocols. By contrast, the lifetime risk of developing colorectal cancer for those people with two or more first degree relatives or one relative diagnosed below the age of 45 without recognised familial syndromes is between 10%-25%, 15 16 and the average lifetime risk in the general population is 2%-5%. 15 16 Therefore, absolute risk of disease has to be weighed against absolute risk of iatrogenic injury as a result of screening 17 ; however, even when taking into account the risks associated with screening procedures such as colonoscopy, this absolute risk may still be great enough to warrant a screening protocol for these people. 16 18 Population screening with faecal occult blood tests, which have been shown to significantly reduce mortality, 19 may provide a more practicable approach to reducing mortality from colorectal cancer. However, although such tests have been shown to have a significant benefit, they have several limitations, 20 including missing many early stage cancers and most premalignant adenomas. There is also the problem of how to investigate those who screen positive, 19 and the cost eVectiveness of such an approach is also still unclear. 21 In the future, the eVectiveness and eYciency of stool screening may be improved by the use of molecular markers. 22 In conclusion, we confirm that a family history of colorectal cancer in first degree relatives is associated with an increased risk of prevalent colorectal cancer. However, based on the prevalence estimates reported here, screening strategies targeted solely at people with a family history will have limited impact on reducing mortality from colorectal cancer at the population level.
